Navigation Links
Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
Date:4/10/2008

SAN DIEGO, April 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will release its first quarter 2008 financial results on Monday, April 28, 2008 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET. Henry L. Nordhoff, chairman and chief executive officer, and Herm Rosenman, senior vice president, finance, and chief financial officer, will host the call.

The conference call will be webcast live and may be accessed on the investors section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 866-421-6934 (U.S.) or 203-369-0825 (international).

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
2. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
3. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
4. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
5. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
6. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
7. LeMaitre Vascular Announces Changes to Its Executive Management Team
8. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
9. Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors
10. IHHI Announces Chief Compliance Officer Appointment
11. The Leukemia & Lymphoma Society Announces Appointment of New President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...that many were convicted since 1990’s, and in 2004...victed //but the Journal of the Royal Society of M...ngeance and retribution, Birmingham City Hospital ...d been charged with manslaughter since 1795. Bec...
...g thousands of rainbow trout.Due to an outbreak, f...ery first case of viral haemorrhagic septicaemia (...ficial across the catchment area of the river Ouse...lso experienced this before on farmed turbot in 19...
...ed that the world would require US $ 22 billion to...er, it is not sure from where the countries will g...dress the issue of AIDS, UN members appreciated th... companies producing generic antiretroviral drugs ...
...was found that Washington employers were paying mo... hospitals and doctors serving Medicare and Medica...tive officer of Mountlake Terrace-based Premera, s... cost-shifting. Others call it a hidden tax’. Thus...
Other Medicine News:
(Date:8/27/2008)...rstCall/ --, - Oralair(R) Grasses 300IR Highly Po... Conducted in an Allergen Challenge Chamber, Stal...s of a new study,conducted in an Allergen Challeng... included 86 adult patients exposed to,grass polle...week, 1 month,2 and 4 months without a titration ...
(Date:8/26/2008)...k SYNTAX clinical trial, NATICK, Mass., Aug. 26 /...tion (NYSE: BSX ) today announced the schedule of...s at the European Society of Cardiology,Congress 2...unich, Germany., The Company plans to announce 12...percutaneous coronary intervention (PCI) using the...
(Date:8/26/2008)...-- Healthpoint today announced,that it has initiat...of a,widely prescribed enzymatic debriding agent o...e pilot study was prompted, in part, by clinical r...ars and beneficial healing,properties associated w...the findings from the peer-reviewed literature, as...
(Date:8/26/2008)...Corporation today announced the,publication of the...g,OMS103HP in arthroscopic anterior cruciate ligam...nvestigational drug product that is added to,arthr...rove postoperative,knee function and motion, reduc... return to work. The article titled "Novel Drug Pr...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Touch Bionics acquires LIVINGSKIN 5421 1Touch Bionics acquires LIVINGSKIN 5421 2Touch Bionics acquires LIVINGSKIN 5421 3Going barefoot 3F Beware 21 19426 1Going barefoot 3F Beware 21 19426 2Eat Your Vegetables That Means You Parents 21 19423 1Eat Your Vegetables That Means You Parents 21 19423 2Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 19420 1Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 19420 2Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 19420 3
...VERTON, R.I., June 18, 2007 /PRNewswire/ -- VeroSc...lthcare product development,company, announced tod...ed as a poster presentation at the 67th Scientific...Chicago, Ill. The abstract,entitled, "Effects of ... Bromocriptine Mesylate) Administration of Safety,...
...TON, Mass.--(BUSINESS WIRE)--Jun 18, 2007 - Novelo...tical company,focused on the development of therap...ced encouraging results in an ongoing,Dana-Farber/...-002,in combination with carboplatin in platinum-r...ents were evaluable for best,overall tumor respons...
Other Medicine Technology:VeroScience Late-Breaking Abstract on Cycloset (A Quick Release,Formulation of Bromocriptine Mesylate) Accepted for Poster,Presentation at American Diabetes Association 67th Scientific,Sessions 2Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 2Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 3
The PachPen uses state-of-the-art waveform analysis and a probe that samples at a 65MHz rate to obtain precise readings. The PachPen stores and averages nine measurements and calculates IOP correctio
...ailable as both regular and filter tips. Sterilize...re efficient sterilization and are delivered with ...e of irradiation. Sterilized Diamond Tips are read...k Diamond Tips are wrapped in medical device quali...
300 L, Bulk Recommended for 250 and 300 L pipettes.
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio
Medicine Products: